Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Areola Tattoo: the End of a Long Therapeutic Process. A Patient's Quality of Life Dedicated Technology

NCT02464982 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT02464982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02464982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Areola Tattoo: the End of a Long Therapeutic Process. A Patient's Quality of Life Dedicated Technology
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
Not reported
Enrollment
107 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, malignant neoplasm reconstruction by tattoo of areola of female breast, right or left breast mammary reconstruction